CDTX vs NKE · rev $1.3M vs P/E 35, rev $46.31B
Cidara Therapeutics Inc (CDTX) versus Nike Inc (NKE) — a side-by-side from cached financials, not a winner call.
Cidara Therapeutics Inc (CDTX) is a biotechnology company listed on US.
Nike Inc (NKE) is a footwear & accessories company listed on US. It is led by John Donahoe.
Latest reported CDTX revenue for 2024-12-31 was $1.3M. Net income was -$169.8M. Revenue was down 94.5% from 2023-12-31 to 2024-12-31. CDTX currently screens at market cap $6.96B.
Latest reported NKE revenue for 2025-05-31 was $46.31B. Net income was $3.22B. NKE currently screens at market cap $110.14B and trailing P/E 34.6.
CDTX currently screens at market cap $6.96B. NKE currently screens at market cap $110.14B and trailing P/E 34.6.
Not investment advice. Open the CDTX and NKE stock pages for the full models.
Not investment advice.